Skip to content

A clinical research on prevention of acute enhancement of chronic obstructive pulmonary disease by traditional Chinese medicine

A clinical research on prevention of acute enhancement of chronic obstructive pulmonary disease by traditional Chinese medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003936
Enrollment
Unknown
Registered
2013-02-19
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

group 1:Yi-qi-gu-biao condensed pill add Pingquan cataplasm
group 2:placebo pill add Pingquan cataplasm
group 3:Yi-qi-gu-biao condensed pill add placebo cataplasm
group 4:placebo pill add placebo cataplasm

Sponsors

Xinjiang national TCM clinical research base
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. aged 40 to 75 years old; 2. the patients conform to the western medicine diagnostic criteria of stable period in COPD; 3. the patients conform to the TCM diagnostic criteria of lung-distension, belongs to the type of lung spleen deficiency "zheng"; 4. not taking related drugs within a week; 5. informed consent, volunteer subjects.

Exclusion criteria

Exclusion criteria: 1. merger of pneumothorax, lung cancer, patients with severe pulmonary tuberculosis and other lung diseases; 2. combined with serious primary diseases such as Cardiovascular and cerebrovascular diseases,Liver and kidney dysfunction,Hematopoietic system diseases; 3. Mental illness; 4. women in pregnancy or lactation; 5. Not according to stipulations medication, unable to determine efficacy or data not congruent effect the outcome; 6. Allergies or allergic to medicines.

Design outcomes

Primary

MeasureTime frame
CAT score;mMRC score;BODE;TCM score;

Secondary

MeasureTime frame
lung function;6mw;

Countries

China

Contacts

Public ContactLi Fengsen
fengsen602@163.com+86 13999980996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026